Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

During the Trading Day
149.80 +0.75 / +0.50%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
149.80 0.00 / 0.00%
 
Volume: 86.9K
How Are Orphan Drugmakers Faring in the Great Biotech Downturn?
6:30pm / MotleyFool.com
Halozyme Falls on Phase II Study Halt - Analyst Blog
Apr 08 / Zacks.com
Emergent BioSolutions Gains on Trial News - Analyst Blog
5:47pm / Zacks.com
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog
Apr 08 / Zacks.com
Transition Therapeutics (TTHI) Jumps: Stock Up 11.5% - Tale of the Tape
9:29am / Zacks.com
FDA Target Date for Gilead's HCV Candidate - Analyst Blog
Apr 08 / Zacks.com
What Falling Estimates & Price Mean for Discovery Laboratories (DSCO) - Tale of the T...
9:13am / Zacks.com
RadNet Touches New 52-Week High - Analyst Blog
Apr 08 / Zacks.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data -...
Apr 16 / Zacks.com
MannKind Slips on Afrezza Approval Delay - Analyst Blog
Apr 08 / Zacks.com
Good News for BioMarin - Analyst Blog
Apr 15 / Zacks.com
Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape
Apr 08 / Zacks.com
FDA Nod for Merck's Grastek - Analyst Blog
Apr 15 / Zacks.com
Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape
Apr 08 / Zacks.com
Pipeline Progress at Coronado Biosciences - Analyst Blog
Apr 14 / Zacks.com
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale ...
Apr 08 / Zacks.com
Positive Results on Intercept Pharma's OCA - Analyst Blog
Apr 14 / Zacks.com
Tweet of the Week: Big Biotech Dominates Industry Gains
Apr 07 / MotleyFool.com
Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
Apr 14 / Zacks.com
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog
Apr 07 / Zacks.com
A Blueprint for Highflier Stability
Apr 14 / TheStreet.com
FDA News Lifts Dyax Slightly - Analyst Blog
Apr 07 / Zacks.com
Stocks bounce back...somewhat
Apr 14 / CNNMoney.com
Exact Sciences Corporation (EXAS) in Focus: Stock Up 5.73% - Tale of the Tape
Apr 07 / Zacks.com
Update on BioLineRx's BL-8040 - Analyst Blog
Apr 11 / Zacks.com
The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog
Apr 04 / Zacks.com
Encouraging Results on Gilead's Sovaldi - Analyst Blog
Apr 11 / Zacks.com
Glaxo and Amgen Terminate Agreement - Analyst Blog
Apr 04 / Zacks.com
Eight pricey stocks haunting the Nasdaq
Apr 11 / Fortune
Response Genetics (RGDX) in Focus: Stock Up 18.3% - Tale of the Tape
Apr 04 / Zacks.com
Positive Data on Biogen/Sobi's Eloctate - Analyst Blog
Apr 11 / Zacks.com
Stocks: brutal finale to week
Apr 04 / CNNMoney.com
Rite Aid (RAD) Jumps: Stock Up 8.4% - Tale of the Tape
Apr 11 / Zacks.com
Weakness Seen in Kindred Biosciences (KIN): Stock Tumbles 9.0% - Tale of the Tape
Apr 04 / Zacks.com
Celladon (CLDN) Jumps: Stock Up 11.5% - Tale of the Tape
Apr 11 / Zacks.com
Good News for Keryx - Analyst Blog
Apr 03 / Zacks.com
Why Alexion Pharmaceuticals, Gilead Sciences, and Monster Beverage Corporation Are To...
Apr 10 / MotleyFool.com
Glaxo Stops MAGE-A3 Lung Cancer Study - Analyst Blog
Apr 03 / Zacks.com
Oh Biotech, You Are a Cruel Bitch
Apr 10 / TheStreet.com
ZIOPHARM Upgraded to Strong Buy - Analyst Blog
Apr 03 / Zacks.com
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog
Apr 10 / Zacks.com
Bayer Initiates Xofigo Combination Study - Analyst Blog
Apr 03 / Zacks.com
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
Apr 08 / Zacks.com
Encouraging Results on Gilead's Sovaldi - Analyst Blog
Apr 03 / Zacks.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog
Apr 08 / Zacks.com
Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape
Apr 03 / Zacks.com
Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog
Apr 08 / Zacks.com
Myriad Genetics (MYGN) Worth Watching: Stock Rises 11.5% - Tale of the Tape
Apr 03 / Zacks.com
Pipeline Update from Idenix - Analyst Blog
Apr 08 / Zacks.com
Should You Get Rid of Synageva BioPharma (GEVA) Now? - Tale of the Tape
Apr 03 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.